Mon panier

Human CD9 Full Length Protein (VLP)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
CD9-H52P3-20ug
$620.00
CD9-H52P3-100ug
$1235.00
CD9-H52P3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    CD9, MIC3, TSPAN29, GIG2, MRP1, BTCC1, DRAP27, 5H9

  • Source

    Human CD9 Full Length Protein (VLP) (CD9-H52P3) is expressed from human 293 cells (HEK293). It contains AA Pro 2 - Val 228 (Accession # P21926).

    Predicted N-terminus: Met

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SEC-HPLC.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SEC-HPLC

    CD9 SEC-HPLC

    The purity of Human CD9 Full Length Protein (VLP) (Cat. No. CD9-H52P3) was greater than 95% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     CD9 ELISA

    Immobilized Human CD9 Full Length Protein (VLP) (Cat. No. CD9-H52P3) at 5 μg/mL (100 μL/well) can bind Anti-CD9 Antibody, Human IgG1 with a linear range of 0.002-0.156 μg/mL (QC tested).

    Protocol
  • Identity-DLS

     CD9 DLS

    The mean peak Radius of VLP is 65-85 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Avis des utilisateurs
Publier un commentaire

Introduction de fond

A tetraspanin broadly expressed on immune cells, platelets, and exosomes. It regulates cell fusion, sperm-egg fusion, and tumor cell motility. CD9 is a canonical exosome marker. In oncology, CD9 can function as either a metastasis suppressor or promoter depending on the cellular context and integrin associations.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    CD9 antigen

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    1 Détails

  • Étape de développement la plus élevée:

    Phase 1 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte